Mayo Clinic News Network

News Resources


Items tagged as "Gastroenterolgy"

Crohn's Disease Study on Infliximab, Azathioprine

A study led by Mayo Clinic has found that infliximab (Remicade®) administered alone (monotherapy) or in combination with azathioprine is a more effective treatment for patients with moderate to severe Crohn’s disease than azathioprine alone. The findings were presented Oct. 6 at the 2008 American College of Gastroenterology (ACG) Annual [...]

Created by Shawn Bishop

Edición electrónica de Discovery’s Edge

Rochester, Minnesota — 8 de enero de 2014 — A continuación se presenta la última edición electrónica de Discovery's Edge, la revista sobre las investigaciones de Mayo Clinic. Usted puede citar y enlazar esta publicación con la frecuencia que desee, pero la reproducción se permite solamente con la debida atribución; [...]

Created by Soledad Andrade

Microbiome Changed by Gluten Increases Incidences of Type 1 Diabetes, say Mayo Clinic Researchers

ROCHESTER, Minn. — Research has shown that the intestinal microbiome plays a large role in the development of Type 1 diabetes. Now, researchers at Mayo Clinic have demonstrated that gluten in the diet may modify the intestinal microbiome, increasing incidences of Type 1 diabetes. The research was published Nov. 13, in the journal PLOS ONE. MULTIMEDIA [...]

Created by Brian Kilen

Mayo Clinic Receives Funding for Gut Function Biomarker Research

ROCHESTER, Minn. — Mayo Clinic announced today that it will receive funding through the Biomarkers of Gut Function and Health program within the Grand Challenges in Global Health initiative. This initiative was launched by the Bill & Melinda Gates Foundation to overcome persistent bottlenecks preventing the creation of new and [...]

Created by mayonewsreleases

Mayo Clinic: Irritable Bowel Syndrome Definitely Isn't 'All in the Head'

ROCHESTER, Minn. — Irritable bowel syndrome is not "all in the head," as has been commonly thought. In a review of the literature, Michael Camilleri, M.D., a Mayo Clinic gastroenterologist and author of an article in the New England Journal of Medicine, describes a renaissance in the understanding of the [...]

Created by mayonewsreleases

Statins May Reduce Risk of Esophageal Cancer

ROCHESTER, Minn. — October 19, 2012.  Statins, a cholesterol lowering drug, may lower the risk of esophageal cancer, especially in patients with Barrett's esophagus, Mayo Clinic researchers report in a study being presented at the American College of Gastroenterology annual meeting. There are two main types of esophageal cancer: squamous [...]

Created by Brian Kilen

C. Diff Infections Becoming More Common, Severe

NOTE: UPDATED EMBARBO TIME OF 8AM ET ROCHESTER, Minn. — October 17, 2012.  Clostridium difficile infections are becoming more common and more severe in hospitalized children and the elderly, in large part due to greater use of antibiotics, Mayo Clinic researchers report in studies being presented at the American College [...]

Created by Brian Kilen

Most With Celiac Disease Unaware of it, Study Reveals

ROCHESTER, Minn. — July 30, 2012.  Roughly 1.8 million Americans have celiac disease, but around 1.4 million of them are unaware that they have it, a Mayo Clinic-led analysis of the condition's prevalence has found. Meanwhile, 1.6 million people in the United States are on a gluten-free diet even though [...]

Created by Brian Kilen

Pancreatic Cancer May Be Detected with Simple Intestinal Probe

JACKSONVILLE, Fla. — May 17, 2012.  By simply shining a tiny light within the small intestine, close to that organ's junction with the pancreas, physicians at Mayo Clinic's campus in Florida have been able to detect pancreatic cancer 100 percent of the time in a small study. The light, attached [...]

Created by Kevin Punsky

Mayo Clinic: Narrow Band Imaging No Significant Advantage in Colonoscopy

SCOTTSDALE, Ariz. — Most patients undergo a colonoscopy with the expectation that any suspicious lesions that may signal evidence of colorectal cancer will be detected. Toward that effort, researchers at Mayo Clinic have compared two types of high definition imaging techniques to determine if one technique is superior over the [...]

Created by mayonewsreleases

Statins Could Effect Risk of Esophageal Cancer

Especially for patients with Barrett’s esophagus, the use of statins may lower the risk of esophageal cancer. Mayo Clinic researchers are presenting their study at the upcoming American College of Gastroenterology annual meeting. “Unfortunately, survival rates for this cancer are low, so prevention is critical,” says Dr. Siddharth Singh, a Mayo Clinic gastroenterologist and study author. [...]

Created by Dana Sparks